About the Company
Unum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immunotherapy products designed to harness the power of a patient’s immune system to cure cancer. The firm’s technologies include Antibody-Coupled T-cell Receptor, which is a chimeric protein that binds to tumor targeting antibodies. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Cambridge, MA.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $UMRX News
Unum (UNM) Enhances Employee Well-Being With Unum Care Hub
Unum Group UNM recently announced the launch of Unum Care Hub to aid employers in taking proper care of their employees. Unum ...
Unum Care Hub will help employers provide support for top leave and disability drivers
Unum (NYSE: UNM), a leading provider of financial protection benefits in the U.S., is launching Unum Care Hub, a suite of ...
Appointments for SunLife and Unum
SunLife adds Victoria Heath as chief marketing officer and Unum welcomes Lio Lopez-Welsch as chief information and digital ...
Loading the latest forecasts...